<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479751</url>
  </required_header>
  <id_info>
    <org_study_id>facilitating RSI</org_study_id>
    <nct_id>NCT01479751</nct_id>
  </id_info>
  <brief_title>Comparison of Methods to Facilitate Rapid Sequence Intubation</brief_title>
  <official_title>Comparison of Mg, Ketamine, Large Dose Rocuronium, and Priming on Intubating Condition in Rapid Sequence Intubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, methods which are known for facilitating rapid sequence intubation or
      accelerating rocuronium (Roc)onset are compared including magnesium (Mg), ketamine
      pretreatment, large dose rocuronium and priming.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are pretreated with Mg, ketamine, or priming dose Roc. Two groups do not receive
      pretreatment, but are given Roc 0.6 mg/kg or 0.9 mg/kg.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation score</measure>
    <time_frame>participants will be followed at the time point of intubation, an expected average of 70 sec from the start of rocuronium injection.</time_frame>
    <description>Patients are tracheally intubated, and intubation scores(poor, good,excellent)are rated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Roc duration</measure>
    <time_frame>participants will be followed when TOF count reaches two, an expected average of 40 min.</time_frame>
    <description>Time from the start of rocuronium injection until reappearance of two muscle twitches in TOF stimulations is measured, using ToF-Watch sx.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roc onset</measure>
    <time_frame>participants will be followed when TOFcount =0 within an expected average of 4 min from the start of rocuronium injection.</time_frame>
    <description>Time from the start of rocuronium injection until TOF count=0 using TOF-Watch sx.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic variables</measure>
    <time_frame>participants will be followed at baseline, before and for 5 min after the intubation, an expected average of 8 min after the start of anesthetic induction.</time_frame>
    <description>Mean arterial pressure (MAP)and heart rate (HR) are measured at baseline, before intubation, and 1, 2, 3, 4, 5 min after intubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TOF% at intubation</measure>
    <time_frame>participants will be followed at the time point of intubation, an expected average of 70 sec from the start of rocuronium injection.</time_frame>
    <description>neumeric value expressed as %, displayed on the monitor of TOF watch-Sx in TOF stimulation (ex. 5% on the display means 95% suppression of T1)</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Intubating Condition</condition>
  <arm_group>
    <arm_group_label>ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive ketamine 0.5 mg/kg 2 min before Roc injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>priming</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Roc 0.9</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive Roc 0.9 mg/kg as an induction dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive Roc 0.6 mg/kg without any pretreatments of Mg, ketamine, or priming.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive magnesium sulfate (MgSO4) 50 mg/kg over 10 min before Roc injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Patients receive MgSO4 50 mg/kg for 10 min before injection of Roc 0.6 mg/kg.</description>
    <arm_group_label>Mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>patients receive ketamine 0.5 mg/kg 2 min before Roc injection.</description>
    <arm_group_label>ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rocuronium</intervention_name>
    <description>Patients receive Roc 0.06 mg/ kg as a priming dose 3 min before injection of Roc 0.54 mg/kg.</description>
    <arm_group_label>priming</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 - 65 years,

          -  ASA 1 - 2,

          -  patients scheduled for elective surgery under general anesthesia,

          -  BMI 18.5-24.9 kg/m2

          -  Mallampati class I-II

        Exclusion Criteria:

          -  neuromuscular disorder,

          -  cardiac/hepatic/renal insufficiency,

          -  pregnant.

          -  anticipated difficult airway

          -  medications that influence neuromuscular transmission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihyun Kim, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang hopital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-Do</state>
        <zip>464-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2011</study_first_posted>
  <last_update_submitted>August 24, 2012</last_update_submitted>
  <last_update_submitted_qc>August 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Kim Mihyun</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <keyword>Rocuronium</keyword>
  <keyword>magnesium</keyword>
  <keyword>priming</keyword>
  <keyword>ketamine</keyword>
  <keyword>intubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

